Sensei Biotherapeutics, Inc.
SNSE
$8.22
$0.020.24%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.57M | -4.94M | -6.86M | -7.77M | -7.25M |
| Total Depreciation and Amortization | 34.00K | 37.00K | 34.00K | 331.00K | 332.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 479.00K | 478.00K | 595.00K | 1.40M | 848.00K |
| Change in Net Operating Assets | 469.00K | -1.49M | -859.00K | 250.00K | 603.00K |
| Cash from Operations | -3.59M | -5.91M | -7.09M | -5.79M | -5.47M |
| Capital Expenditure | 0.00 | -16.00K | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | 0.00 | 210.00K | 40.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.74M | 8.56M | 7.15M | -3.15M | 12.91M |
| Cash from Investing | 1.74M | 8.76M | 7.19M | -3.15M | 12.91M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -152.00K | -314.00K | -211.00K | -207.00K | -204.00K |
| Issuance of Common Stock | 0.00 | 5.00K | -- | 13.00K | 0.00 |
| Repurchase of Common Stock | -1.00K | 0.00 | -3.00K | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.00K | 141.00K | -- | -- | -- |
| Cash from Financing | -152.00K | -168.00K | -214.00K | -194.00K | -204.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.00M | 2.68M | -117.00K | -9.14M | 7.24M |